Related Experiment Video
Updated: Apr 11, 2026
06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
12.8K
LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?
1Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Current Cardiology Reports
|June 3, 2015
Summary
Genetic studies reveal new insights into lipid metabolism and coronary artery disease (CAD). These findings are paving the way for novel treatments, like PCSK9 inhibitors, to manage CAD risks.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Genetic studies have significantly advanced our understanding of lipid metabolism.
- Lipid traits are intrinsically linked to the development of coronary artery disease (CAD).
- Emerging genetic insights highlight novel pathways and interactions in lipid metabolism relevant to CAD.
Purpose of the Study:
- To review recent genetic findings on lipid metabolism and CAD.
- To discuss the implications of these genetic discoveries for understanding CAD.
- To explore the development of novel therapeutic strategies informed by genetic research.
Main Methods:
- Review of recent genetic studies focusing on lipid traits and CAD.
- Analysis of genetic pathways and interactions in lipid metabolism.
- Evaluation of current and emerging therapeutic strategies, including PCSK9 inhibition.
Main Results:
- Genetic studies have identified key relationships between lipid metabolism and CAD.
- Novel pathways and interactions influencing lipid metabolism have been uncovered.
- These genetic insights support the development of targeted therapies like PCSK9 inhibitors for CAD.
Conclusions:
- Genetic research provides a deeper understanding of lipid metabolism's role in CAD.
- Genetic discoveries are driving the development of innovative treatment strategies for CAD.
- Targeting lipid metabolism through genetic insights offers promising avenues for CAD prevention and treatment.
More Related Videos
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
866
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
01:26Atherosclerosis III: Management
602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
01:29Pharmacogenomics: Identification of New Drug Targets
91
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
91
01:30Coronary Artery Disease I: Introduction
1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
110
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
110